Publications by authors named "Megan Chryst-Stangl"

Introduction: The etiology of most cases of nephrotic syndrome (NS) remains unknown, therefore patients are phenotypically categorized based on response to corticosteroid therapy as steroid sensitive NS (SSNS), or steroid resistant NS (SRNS). Genetic risk factors have been identified for SSNS from unbiased genome-wide association studies (GWAS), however it is unclear if these loci are disease risk loci in other forms of NS such as SRNS. Additionally, it remains unknown if these risk loci are associated with response to therapy.

View Article and Find Full Text PDF

Background: Focal segmental glomerulosclerosis (FSGS) is a major cause of end stage kidney disease, with the collapsing form having the worst prognosis. Study of families with hereditary FSGS has provided insight into disease mechanisms.

Methods: In this report, we describe a sibling pair with mutations and collapsing FSGS (cFSGS).

View Article and Find Full Text PDF

Glomerular diseases (GDs) are a major cause of chronic kidney disease in children. The conventional approach to diagnosis of GDs includes clinical evaluation and, in most cases, kidney biopsy to make a definitive diagnosis. However, in many cases, clinical presentations of different GDs can overlap, leading to uncertainty in diagnosis and management even after renal biopsy.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers discovered a variant (p.H310Y) in the CLVS1 gene linked to familial steroid-sensitive nephrotic syndrome (SSNS) in a consanguineous family with three affected members.
  • In zebrafish and human podocytes, this variant resulted in issues with podocyte structure, impaired endocytosis, and increased susceptibility to apoptosis, which could be reversed by corticosteroid treatment.
  • The study highlights the role of CLVS1 in podocyte function, emphasizing the significance of endocytosis and oxidative stress management in SSNS, and suggests potential therapeutic pathways through corticosteroids.
View Article and Find Full Text PDF

Background: Podocyte dysfunction is the main pathologic mechanism driving the development of FSGS and other morphologic types of steroid-resistant nephrotic syndrome (SRNS). Despite significant progress, the genetic causes of most cases of SRNS have yet to be identified.

Methods: Whole-genome sequencing was performed on 320 individuals from 201 families with familial and sporadic NS/FSGS with no pathogenic mutations in any known NS/FSGS genes.

View Article and Find Full Text PDF

To understand the genetics of steroid-sensitive nephrotic syndrome (SSNS), we conducted a genome-wide association study in 987 childhood SSNS patients and 3,206 healthy controls with Japanese ancestry. Beyond known associations in the HLA-DR/DQ region, common variants in NPHS1-KIRREL2 (rs56117924, P=4.94E-20, odds ratio (OR) =1.

View Article and Find Full Text PDF

Steroid-resistant nephrotic syndrome (SRNS) is a leading cause of end-stage kidney disease in children and young adults. Despite advances in genomic science that have led to the discovery of >50 monogenic causes of SRNS, there are no clear guidelines for genetic testing in clinical practice. Using high throughput sequencing, we evaluated 492 individuals from 181 families for mutations in 40 known SRNS genes.

View Article and Find Full Text PDF

Background: We previously reported that mutations in the anillin () gene cause familial forms of FSGS. ANLN is an F-actin binding protein that modulates podocyte cell motility and interacts with the phosphoinositide 3-kinase (PI3K) pathway through the slit diaphragm adaptor protein CD2-associated protein (CD2AP). However, it is unclear how the mutations cause the FSGS phenotype.

View Article and Find Full Text PDF